Pricing Log in Create free account

BioXcel Therapeutics, Inc. (BTAIQ) vs cbdMD, Inc. (YCBD)

BioXcel Therapeutics, Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. cbdMD, Inc. is the larger, with a market value of $4.4M against $2.3M — 1.9× the size. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −14.5%. cbdMD, Inc. has the higher net margin (−14.7% vs −9,549.9%) and the lower return on invested capital (−29.8% vs 0.00%). Across the 16 metrics below, cbdMD, Inc. leads on 12 and BioXcel Therapeutics, Inc. on 4.

Valuation

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.41 0.19 2.08
P/B n/m 0.49 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 227.51 0.21 2.87
Earnings yield (37,900.00%) (80.50%) (15.94%)
Free cash flow yield (16,806.60%) (61.46%) 0.00%

Profitability

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
Gross margin 53.10% 57.68% 53.51%
Operating margin (6,054.72%) (13.87%) 0.00%
Net margin (9,549.87%) (14.71%) (2.45%)
Free cash flow margin (6,860.38%) (11.51%) 0.00%
Return on equity 63.52% (43.01%) (0.80%)
Return on assets (259.62%) (26.73%) (1.67%)
Return on invested capital 0.00% (29.78%) 0.00%

Growth

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (14.52%) 10.01% 5.22%
EPS growth (last fiscal year) 75.63% 92.39% 42.91%
Revenue growth, 5-year CAGR — (14.45%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.00 0.04
Current ratio 0.21 2.50 2.41
Net debt to EBITDA (1.61) 6.17 1.01

Dividend

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BTAIQ YCBD Drug Manufacturers Specialty & Generic median
Market cap 2.31m 4.35m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack